Hit tumors* hard with TheraSphere.
Highly Powerful Y-90 Radiation Embedded Within Each Glass Microsphere
- Arrives in a custom sealed source vial with an easy and safe set-up
- Infusion does not require contrast to evaluate flow due to minimally embolic properties and takes less than five minutes
- Minimal opportunities for residual and no concern over stasis or reflux
- Salem R, Gabr A, Riaz A, et al. Institutional decision to adopt Y-90 as primary treatment for HCC informed by a 1,000-patient 15-year experience. Hepatology. 2017 Dec 1.
*Refers to HCC or associated tumors